Material Safety Data Sheet Section 1. Identification of the substance 3-Fluoro-5-methoxybenzaldehyde Product Name: Synonyms: Section 2. Hazards identification Harmful by inhalation, in contact with skin, and if swallowed. H315: Causes skin irritation H319: Causes serious eye irritation H335: May cause respiratory irritation P261: Avoid breathing dust/fume/gas/mist/vapours/spray Wear protective gloves/protective clothing/eye protection/face protection P280: P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do – continue rinsing P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing P405: Store locked up Section 3. Composition/information on ingredients. 3-Fluoro-5-methoxybenzaldehyde Ingredient name: CAS number: 699016-24-5 Section 4. First aid measures Immediately wash skin with copious amounts of water for at least 15 minutes while removing Skin contact: contaminated clothing and shoes. If irritation persists, seek medical attention. Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical attention. Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention. Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention. Ingestion: Section 5. Fire fighting measures In the event of a fire involving this material, alone or in combination with other materials, use dry powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus should be worn. Section 6. Accidental release measures Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national standards. Respiratory precaution: Wear approved mask/respirator Hand precaution: Wear suitable gloves/gauntlets Skin protection: Wear suitable protective clothing Eye protection: Wear suitable eye protection Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container for disposal. See section 12. Environmental precautions: Do not allow material to enter drains or water courses. Section 7. Handling and storage Handling: This product should be handled only by, or under the close supervision of, those properly qualified in the handling and use of potentially hazardous chemicals, who should take into account the fire, health and chemical hazard data given on this sheet. Storage: Store in closed vessels, refrigerated. Section 8. Exposure Controls / Personal protection Engineering Controls: Use only in a chemical fume hood. Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles. General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse. Section 9. Physical and chemical properties Not specified Appearance: Boiling point: No data Melting point: No data Flash point: No data Density: No data Molecular formula: C8H7FO2 Molecular weight: 154.1 Section 10. Stability and reactivity Conditions to avoid: Heat, flames and sparks. Materials to avoid: Oxidizing agents. Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride. Section 11. Toxicological information No data. Section 12. Ecological information No data. Section 13. Disposal consideration Arrange disposal as special waste, by licensed disposal company, in consultation with local waste disposal authority, in accordance with national and regional regulations. Section 14. Transportation information Non-harzardous for air and ground transportation. Section 15. Regulatory information No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302, or have known CAS numbers that exceed the threshold reporting levels established by SARA Title III, Section 313.
1,2-Diarylimidazoles as Potent, Cyclooxygenase-2 Selective, and Orally Active Antiinflammatory Agents
摘要:
Series of 1,2-diarylimidazoles has been synthesized and found to contain highly potent and selective inhibitors of the human COX-2 enzyme. The paper describes a short synthesis of the target 1,2-diarylimidazoles starting with aryl nitriles. Different portions of the diarylimidazole (I) were modified to establish SAR. Systematic variations of the substituents in the aryl ring B have yielded very potent (IC50 = 10-100 nm) and selective (1000-12500) inhibitors of the COX-2 enzyme. The study on the influence of substituents in the imidazole ring established that a CF3 group at position 4 gives the optimum oral activity. A number of the diarylimidazoles showed excellent inhibition in the adjuvant induced arthritis model (e.g., ED50 = 0.02 mph for 22 and 34). The diarylimidazoles are also potent inhibitors of carrageenan-induced edema (ED50 = 9-30 mph) sind hyperalgesia (ED50 = 11-40 mpk). Several orally active diarylimidazoles show no GI toxicity in the rat and mouse up to 200 mpk.
크로만 유도체 및 이를 유효성분으로 함유하는 신생혈관성 안질환 또는 암의 예방 또는 치료용 약학적 조성물
申请人:Gachon University of Industry-Academic cooperation Foundation 가천대학교 산학협력단(220040376324) BRN ▼129-82-07687
公开号:KR20200124630A
公开(公告)日:2020-11-03
본 발명은 크로만 유도체인 하기 화학식 1의 화합물, 이의 수화물, 이의 입체 이성질체, 또는 이의 약학적으로 허용 가능한 염을 포함하는 암 또는 신생혈관과 관련된 질환 치료용 약학적 조성물을 제공한다. [화학식 1] (상기 화학식 1에서 R, R, R, R, R, R, R은 발명의 설명에서 정의한 바와 같다.)
[EN] ACYL HYDRAZONE LINKERS, METHODS AND USES THEREOF<br/>[FR] LIEURS D'ACYLHYDRAZONE, PROCÉDÉS ET UTILISATIONS
申请人:ONTARIO INSTITUTE FOR CANCER RES OICR
公开号:WO2019109188A1
公开(公告)日:2019-06-13
The present application is directed to compounds of Formula (I)-(VI): (I), (II), (III), (IV), (V) (VI), (VII) and (VIII), compositions comprising these compounds and their uses, for example as medicaments and/or diagnostics.
Pseudomonasaeruginosa (P. aeruginosa) is an opportunistic human pathogen that forms biofilms and produces virulence factors viaquorumsensing (QS). Blocking the QS system in P. aeruginosa is an excellent strategy to reduce biofilm formation and the production of virulence factors. RhlR plays an essential role in the QS system of P. aeruginosa. We synthesized 55 analogues based on the chemical structure
[EN] COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS ET LEURS UTILISATIONS
申请人:FOGHORN THERAPEUTICS INC
公开号:WO2021155320A1
公开(公告)日:2021-08-05
The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
本公开涉及用于治疗BAF复合物相关疾病的化合物。
[EN] PYRROLIDINE COMPOUNDS<br/>[FR] COMPOSÉS DE PYRROLIDINE
申请人:LILLY CO ELI
公开号:WO2020247429A1
公开(公告)日:2020-12-10
The present invention provides compounds of the Formula (I) wherein L is selected from the group consisting of -CH2NHCH2-, -CH2NH-, -NH-, -S-, -S(O)-, -S(O)2-, -O-, -OCH2-, -OCH2CH2O-, -NHSO2NH-, (II) and (III), or a pharmaceutically acceptable salt thereof; a compound of the formula: (IV), processes for preparing the compounds and their salts, a pharmaceutical composition, and methods of treating patients in need of such treatment.